Gerresheimer AG reported strong growth in the third quarter of the 2011 financial year, with the company stating revenue growth of 9.9% to €285.1 million for the quarter (June 1, 2011 to August 31, 2011). At constant exchange rates, the growth rate compared to last year is 13.4%. Net income grew by 36% to €19.2 million.
“With a strong burst of growth in the third quarter we gained ground and further developed our strong market position. Our medical plastics systems business did extremely well. As a result, we have raised our revenue guidance for the current year to 7–8% growth at constant exchange rates,” said Uwe Röhrhoff, CEO of Gerresheimer AG. “The pharma market will continue to grow. However, the main growth drivers will change. In future, main growth drivers will be the emerging markets and the generic drugs, whilst complex drug delivery systems are gaining significance in Western industrialized nations. We are already in an excellent position to satisfy these changing requirements with our comprehensive product portfolio, and our strong presence in South America and China and we are going to strengthen our position further.”